Background Recognizing the rapidly increasing interest and evidence in using metastasis-
directed radiotherapy (MDRT) for oligometastatic disease (OMD), ESTRO and ASTRO …

Oligoprogressive disease is a relatively new clinical concept describing progression at only
a few sites of metastasis in patients with otherwise controlled widespread disease. In the era …

It is not clear as to which is the best treatment among surgery and stereotactic radiotherapy
(SBRT) for lung oligometastases. A systematic review of literature with a priori selection …

Background Patients with oligometastatic disease can potentially be cured by using an
ablative therapy for all active lesions. Stereotactic body radiotherapy (SBRT) is a non …

Aim: This study was performed to confirm the superior overall survival (OS) after pulmonary
oligo-recurrence compared to pulmonary sync-oligometastases in a large nationwide study …

Introduction: Selected patients with locally advanced or metastatic soft tissue and bone
sarcomas (STBS) may benefit from intensive local treatment, such as stereotactic …

Background This study evaluated the treatment results of lymph node (LN) oligo-recurrence
in esophageal cancer patients treated with salvage radiotherapy (RT) in a multi-institutional …

With the emergence of lung cancer screening programmes and newly detected localised
and multifocal disease, novel treatment compounds and multimodal treatment approaches …

Background/Aim: To investigate the usefulness of cell-free DNA (cfDNA) in patients with
oligometastasis. Patients and Methods: This study included oligometastatic colorectal …

Background/Aim: The aim of this multi-center retrospective study was to investigate the
results of stereotactic body radiotherapy (SBRT) for pulmonary oligometastases from …